IL6 and colorectal carcinoma: Chronic inflammation plays a critical role in both the initiation and progression of CRC, with interleukin-6 (IL-6) recognized as a key pro-tumorigenic mediator (Lu et al., 2025; Zhou et al., 2025; Turano et al., 2021).